Health

Expert Panel Against Permitting Serum Institute To Conduct Trials Of Covovax On Children

An expert panel on COVID-19, of the Central Drugs Standard Control Organisation (CDSCO), has recommended against granting approval to the Serum Institute of India (SII) to conduct the Phase 2 and 3 trial of the vaccine Covovax on children aged between two and 17.The vaccine manufacturer had applied...